ATPW
GSK icon

Ashton Thomas Private Wealth’s GSK GSK Stock Holding History

Ashton Thomas Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.18M Buy
79,687
+9,570
+14% +$506K 0.09% 233
2026
Q1 		$3.87M Buy
70,117
+9,336
+15% +$506K 0.09% 234
2025
Q4 		$3.01M Sell
60,781
-33
-0.1% -$1.54K 0.07% 262
2025
Q3 		$2.65M Buy
60,814
+229
+0.4% +$8.95K 0.07% 277
2025
Q2 		$2.34M Buy
60,585
+41,430
+216% +$1.58M 0.08% 250
2025
Q1 		$750K Sell
19,155
-586
-3% -$21.5K 0.03% 454
2024
Q4 		$675K Buy
+19,741
New +$711K 0.03% 473
2024
Q3 		– Sell
-952
Closed -$36.7K – 1120
2024
Q2 		$36.7K Buy
+952
New +$40K ﹤0.01% 999

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ashton Thomas Private Wealth's GSK Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its GSK (GSK) stake by 14% in Q2 2026, buying an estimated $506K and bringing the position to 79,687 shares worth $4.18M. The position accounts for 0.09% of the portfolio, ranked #233.

Ashton Thomas Private Wealth first reported a position in GSK in Q2 2024 and has held it in 8 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ashton Thomas Private Wealth held 79,687 shares of GSK worth $4.18M as of Q2 2026.
  • Ashton Thomas Private Wealth bought 9,570 GSK shares in Q2 2026, an estimated $506K.
  • GSK made up 0.09% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #233 holding.
  • Ashton Thomas Private Wealth first reported a position in GSK in Q2 2024 and has held it in 8 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.